• 6767 Bertner Ave, Mitchell Basic Science Research Building

    77030 Houston

    United States

  • 56973 Citations
  • 105 h-Index
1977 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Aman U Buzdar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1977 2019

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno-Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. & 1 others, Weinshilboum, R. M., Jul 2019, In : Clinical pharmacology and therapeutics. 106, 1, p. 219-227 9 p.

Research output: Contribution to journalArticle

Open Access
Aromatase Inhibitors
Genome-Wide Association Study
Single Nucleotide Polymorphism
Pharmaceutical Preparations
Breast Neoplasms
4 Citations (Scopus)

Disease-Free and Overall Survival among Patients with Operable HER2-Positive Breast Cancer Treated with Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial

Buzdar, A. U., Suman, V. J., Meric-Bernstam, F., Leitch, A. M., Ellis, M. J., Boughey, J. C., Unzeitig, G. W., Royce, M. E. & Hunt, K. K., Jan 2019, In : JAMA Oncology. 5, 1, p. 45-50 6 p.

Research output: Contribution to journalArticle

Disease-Free Survival
Arm
Randomized Controlled Trials
Breast Neoplasms
Drug Therapy
4 Citations (Scopus)

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer

Yam, C., Murthy, R. K., Valero, V., Szklaruk, J., Shroff, G. S., Stalzer, C. J., Buzdar, A. U., Murray, J. L., Yang, W., Hortobagyi, G. N., Moulder, S. L. & Arun, B., Apr 1 2018, In : Investigational New Drugs. 36, 2, p. 299-306 8 p.

Research output: Contribution to journalArticle

gemcitabine
tipifarnib
Breast Neoplasms
Confidence Intervals
Farnesyltranstransferase
9 Citations (Scopus)
Clinical Trials
Neoplasms
Health Care Costs
Biomedical Research
Industry
17 Citations (Scopus)

Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial

Lesurf, R., Griffith, O. L., Griffith, M., Hundal, J., Trani, L., Watson, M. A., Aft, R., Ellis, M. J., Ota, D., Suman, V. J., Meric-Bernstam, F., Leitch, A. M., Boughey, J. C., Unzeitig, G., Buzdar, A. U., Hunt, K. K. & Mardis, E. R., May 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, 5, p. 1070-1077 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
RNA
erbB-2 Genes
Exome